Following a well-attended AGM, Life Sciences BC is pleased to announce new Board of Directors members, with thanks to those who are departing.

At today’s AGM, Max Blouw (President, Research Universities Council of British Columbia), Kevin Chaplin (CEO, Kardium), Bob Dawson (National Director, Access and Government Relations, Pfizer), and Wendy Hurlburt (President and CEO, Life Sciences BC), were elected to the Board of Directors for a three-year term.

Also at today’s AGM, former Board Chair, Nancy Harrison and Dr. Gavin Stuart, who have both made significant contributions to the organization and its overall management in the last several years, left the Board of Directors. Life Sciences BC thanks Nancy and Gavin, both longstanding Board members, for their years of leadership and looks forward to their continuing leadership in the BC life sciences sector.

At today’s Board of Directors meeting, it was announced that Scott Phillips will continue as Chair, Board of Directors with Ali Ardakani remaining as Vice Chair. Rajveer Hundal will stay on as Treasurer and Chair of the Finance Committee.

“I look forward to another term as Chair on the LSBC Board of Directors. It’s an honour to serve alongside this distinguished and professional group. I am more confident than ever that the BC life sciences sector, with our science, industry talent and entrepreneurial excellence, can play a key part in the economic recovery of the province. We have a long history of supporting each other in this sector and this remarkable board is an embodiment of that spirit.”

Scott Phillips, Life Sciences BC Board Chair and CEO of Starfish Medical

To see the full list of Life Sciences BC’s Board of Directors please visit our website.

About Life Sciences BC

Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and promotion of our world-class science and industry.

Life sciences sectors, from biopharmaceuticals and medical technology to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.

Throughout the year, Life Sciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210916005931/en/